Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Skeletal Radiology
Published in: Skeletal Radiology 6/2024

02-12-2023 | Metastasis | Scientific Article

Multiparametric quantification of T1 and T2 relaxation time of bone metastasis in comparison with red or fatty bone marrow using magnetic resonance fingerprinting

Authors: Hokyun Byun, Dongyeob Han, Ho Jong Chun, Sheen-Woo Lee

Published in: Skeletal Radiology | Issue 6/2024

Login to get access

Abstract

Objectives

To assess the T1 and T2 values of bone marrow lesions in spine and pelvis derived from magnetic resonance fingerprinting (MRF) and to evaluate the differences in values among bone metastasis, red marrow and fatty marrow.

Methods

Sixty patients who underwent lumbar spine and pelvic MRI with magnetic resonance fingerprinting were retrospectively included. Among eligible patients, those with bone metastasis, benign red marrow deposition and normal fatty marrow were identified. Two radiologists independently measured the T1 and T2 values from metastatic bone lesions, fatty marrow, and red marrow deposition on three-dimensional-magnetic resonance fingerprinting. Intergroup comparison and interobserver agreement were analyzed.

Results

T1 relaxation time was significantly higher in osteoblastic metastasis than in red marrow (1674.6 ± 436.3 vs 858.7 ± 319.5, p < .001). Intraclass correlation coefficients for T1 and T2 values were 0.96 (p < 0.001) and 0.83 (p < 0.001), respectively. T2 relaxation time of osteoblastic metastasis and red marrow deposition had no evidence of a difference (osteoblastic metastasis, 57.9 ± 25.0 vs red marrow, 58.0 ± 34.4, p = 0.45), as were the average T2 values of osteolytic metastasis and red marrow deposition (osteolytic metastasis, 45.3 ± 15.1 vs red marrow, 58.0 ± 34.4, p = 0.63).

Conclusions

We report the feasibility of three-dimensional-magnetic resonance fingerprinting based quantification of bone marrow to differentiate bone metastasis from red marrow. Simultaneous T1 and T2 quantification of metastasis and red marrow deposition was possible in spine and pelvis and showed significant different values with excellent inter-reader agreement.

Advance in knowledge

T1 values from three-dimensional-magnetic resonance fingerprinting might be a useful quantifier for evaluating bone marrow lesions.
Literature
1.
Swartz PG, Roberts CC. Radiological reasoning: bone marrow changes on MRI. AJR Am J Roentgenol. 2009;193(3):S1-4-S5-9.PubMed
2.
Woolf DK, Padhani AR, Makris A. Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care? Ann Oncol. 2015;26(6):1048–57.PubMedCrossRef
3.
Maeder Y, Dunet V, Richard R, Becce F, Omoumi P. Bone Marrow Metastases: T2-weighted Dixon Spin-Echo Fat Images Can Replace T1-weighted Spin-Echo Images. Radiology. 2018;286(3):948–59.PubMedCrossRef
4.
Vanel D, Missenard G, Le Cesne A, Guinebretière JM. Red marrow recolonization induced by growth factors mimicking an increase in tumor volume during preoperative chemotherapy: MR study. J Comput Assist Tomogr. 1997;21(4):529–31.PubMedCrossRef
5.
Sakamoto A, Otsuki B, Okamoto T, Goto T, Yoshimura T, Matsuda S. Diffuse Appearance of Red Bone Marrow on MRI Mimics Cancer Metastasis and Might be Associated with Heavy Smoking. Open Orthop J. 2018;12(1):451–61.CrossRef
6.
7.
Karampinos DC, Ruschke S, Dieckmeyer M, Diefenbach M, Franz D, Gersing AS, et al. Quantitative MRI and spectroscopy of bone marrow. J Magn Reson Imaging. 2018;47(2):332–53.PubMedCrossRef
8.
Zhou XJ, Leeds NE, McKinnon GC, Kumar AJ. Characterization of benign and metastatic vertebral compression fractures with quantitative diffusion MR imaging. AJNR Am J Neuroradiol. 2002;23(1):165–70.PubMedPubMedCentral
9.
Chan J, Peh W, Tsui E, Chau L, Cheung K, Chan K, et al. Acute vertebral body compression fractures: discrimination between benign and malignant causes using apparent diffusion coefficients. Br J Radiol. 2002;75(891):207–14.PubMedCrossRef
10.
Suh CH, Yun SJ, Jin W, Lee SH, Park SY, Ryu CW. ADC as a useful diagnostic tool for differentiating benign and malignant vertebral bone marrow lesions and compression fractures: a systematic review and meta-analysis. Eur Radiol. 2018;28(7):2890–902.PubMedCrossRef
11.
Bray TJ, Chouhan MD, Punwani S, Bainbridge A, Hall-Craggs MA. Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology. Br J Radiol. 2018;91(1089):20170344.PubMed
12.
Leplat C, Hossu G, Chen B, De Verbizier J, Beaumont M, Blum A, et al. Contrast-Enhanced 3-T Perfusion MRI With Quantitative Analysis for the Characterization of Musculoskeletal Tumors: Is It Worth the Trouble? AJR Am J Roentgenol. 2018;211(5):1092–8.PubMedCrossRef
13.
Jiang Y, Ma D, Seiberlich N, Gulani V, Griswold MA. MR fingerprinting using fast imaging with steady state precession (FISP) with spiral readout. Magn Reson Med. 2015;74(6):1621–31.PubMedCrossRef
14.
Jiang Y, Ma D, Keenan KE, Stupic KF, Gulani V, Griswold MA. Repeatability of magnetic resonance fingerprinting T1 and T2 estimates assessed using the ISMRM/NIST MRI system phantom. Magn Reson Med. 2017;78(4):1452–7.PubMedCrossRef
15.
Buonincontri G, Biagi L, Retico A, Cecchi P, Cosottini M, Gallagher FA, et al. Multi-site repeatability and reproducibility of MR fingerprinting of the healthy brain at 1.5 and 3.0 T. Neuroimage. 2019;195:362–72.PubMedCrossRef
16.
Körzdörfer G, Kirsch R, Liu K, Pfeuffer J, Hensel B, Jiang Y, et al. Reproducibility and repeatability of MR fingerprinting relaxometry in the human brain. Radiology. 2019;292(2):429–37.PubMedCrossRef
17.
Han D, Choi MH, Lee YJ, Kim DH. Feasibility of Novel Three-Dimensional Magnetic Resonance Fingerprinting of the Prostate Gland: Phantom and Clinical Studies. Korean J Radiol. 2021;22(8):1332–40.PubMedPubMedCentralCrossRef
18.
Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116–28.PubMedCrossRef
19.
20.
Saifuddin A, Tyler P, Rajakulasingam R. Imaging of bone marrow pitfalls with emphasis on MRI. Br J Radiol. 2023;96(1142):20220063.PubMedCrossRef
21.
Akay S, Kocaoglu M, Emer O, Battal B, Arslan N. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms. J Med Imaging Radiat Oncol. 2013;57(3):274–82.PubMedCrossRef
22.
Ghanem N, Lohrmann C, Engelhardt M, Pache G, Uhl M, Saueressig U, et al. Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol. 2006;16(5):1005–14.PubMedCrossRef
23.
Lecouvet FE, El Mouedden J, Collette L, Coche E, Danse E, Jamar F, et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol. 2012;62(1):68–75.PubMedCrossRef
24.
25.
Messiou C, Hillengass J, Delorme S, Lecouvet FE, Moulopoulos LA, Collins DJ, et al. Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS). Radiology. 2019;291(1):5–13.PubMedCrossRef
26.
Pasoglou V, Michoux N, Larbi A, Van Nieuwenhove S, Lecouvet F. Whole Body MRI and oncology: recent major advances. Br J Radiol. 2018;91(1090):20170664.PubMedPubMedCentralCrossRef
27.
McElroy S, Winfield JM, Westerland O, Charles-Edwards G, Bell J, Neji R, et al. Integrated slice-specific dynamic shimming for whole-body diffusion-weighted MR imaging at 1.5 T. MAGMA. 2021;34(4):513–21.PubMedCrossRef
28.
Badve C, Yu A, Rogers M, Ma D, Liu Y, Schluchter M, et al. Simultaneous T(1) and T(2) Brain Relaxometry in Asymptomatic Volunteers using Magnetic Resonance Fingerprinting. Tomography. 2015;1(2):136–44.PubMedPubMedCentralCrossRef
29.
Badve C, Yu A, Dastmalchian S, Rogers M, Ma D, Jiang Y, et al. MR Fingerprinting of Adult Brain Tumors: Initial Experience. AJNR Am J Neuroradiol. 2017;38(3):492–9.PubMedPubMedCentralCrossRef
30.
Chen Y, Panda A, Pahwa S, Hamilton JI, Dastmalchian S, McGivney DF, et al. Three-dimensional MR Fingerprinting for Quantitative Breast Imaging. Radiology. 2019;290(1):33–40.PubMedCrossRef
31.
Panda A, Chen Y, Ropella-Panagis K, Ghodasara S, Stopchinski M, Seyfried N, et al. Repeatability and reproducibility of 3D MR fingerprinting relaxometry measurements in normal breast tissue. J Magn Reson Imaging. 2019;50(4):1133–43.PubMedPubMedCentralCrossRef
32.
Liu Y, Hamilton J, Rajagopalan S, Seiberlich N. Cardiac Magnetic Resonance Fingerprinting: Technical Overview and Initial Results. JACC Cardiovasc Imaging. 2018;11(12):1837–53.PubMedPubMedCentralCrossRef
33.
Coristine AJ, Hamilton J, van Heeswijk RB, Hullin R, Seiberlich N. Cardiac magnetic resonance fingerprinting in heart transplant recipients.
34.
Cloos MA, Assländer J, Abbas B, Fishbaugh J, Babb JS, Gerig G, et al. Rapid Radial T(1) and T(2) Mapping of the Hip Articular Cartilage With Magnetic Resonance Fingerprinting. J Magn Reson Imaging. 2019;50(3):810–5.PubMedCrossRef
35.
Koolstra K, Beenakker JM, Koken P, Webb A, Börnert P. Cartesian MR fingerprinting in the eye at 7T using compressed sensing and matrix completion-based reconstructions. Magn Reson Med. 2019;81(4):2551–65.PubMedCrossRef
36.
Ma D, Jones SE, Deshmane A, Sakaie K, Pierre EY, Larvie M, et al. Development of high-resolution 3D MR fingerprinting for detection and characterization of epileptic lesions. J Magn Reson Imaging. 2019;49(5):1333–46.PubMedCrossRef
37.
Liao C, Wang K, Cao X, Li Y, Wu D, Ye H, et al. Detection of Lesions in Mesial Temporal Lobe Epilepsy by Using MR Fingerprinting. Radiology. 2018;288(3):804–12.PubMedCrossRef
38.
Chen Y, Jiang Y, Pahwa S, Ma D, Lu L, Twieg MD, et al. MR Fingerprinting for Rapid Quantitative Abdominal Imaging. Radiology. 2016;279(1):278–86.PubMedCrossRef
39.
Su P, Mao D, Liu P, Li Y, Pinho MC, Welch BG, et al. Multiparametric estimation of brain hemodynamics with MR fingerprinting ASL. Magn Reson Med. 2017;78(5):1812–23.PubMedCrossRef
40.
Cloos MA, Knoll F, Zhao T, Block KT, Bruno M, Wiggins GC, et al. Multiparametric imaging with heterogeneous radiofrequency fields. Nat Commun. 2016;7:12445.PubMedPubMedCentralCrossRef
41.
Chen Y, Chen MH, Baluyot KR, Potts TM, Jimenez J, Lin W. MR fingerprinting enables quantitative measures of brain tissue relaxation times and myelin water fraction in the first five years of life. Neuroimage. 2019;186:782–93.PubMedCrossRef
42.
Arita Y, Takahara T, Yoshida S, Kwee TC, Yajima S, Ishii C, et al. Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging. Invest Radiol. 2019;54(10):638–44.PubMedCrossRef
43.
Choi MH, Lee SW, Kim HG, Kim JY, Oh SW, Han D, et al. 3D MR fingerprinting (MRF) for simultaneous T1 and T2 quantification of the bone metastasis: Initial validation in prostate cancer patients. Eur J Radiol. 2021;144:109990.PubMedCrossRef
44.
Sharafi A, Medina K, Zibetti MWV, Rao S, Cloos MA, Brown R, et al. Simultaneous T1, T2, and T1rho relaxation mapping of the lower leg muscle with MR fingerprinting. Magn Reson Med. 2021;86(1):372–81.PubMedPubMedCentralCrossRef
45.
Nolte T, Gross-Weege N, Doneva M, Koken P, Elevelt A, Truhn D, et al. Spiral blurring correction with water-fat separation for magnetic resonance fingerprinting in the breast. Magn Reson Med. 2020;83(4):1192–207.PubMedCrossRef
46.
Jaubert O, Cruz G, Bustin A, Hajhosseiny R, Nazir S, Schneider T, et al. T1, T2, and Fat Fraction Cardiac MR Fingerprinting: Preliminary Clinical Evaluation. J Magn Reson Imaging. 2021;53(4):1253–65.PubMedCrossRef
47.
Marty B, Reyngoudt H, Boisserie JM, Le Louër J, Araujo CAE, Fromes Y, et al. Water-Fat Separation in MR Fingerprinting for Quantitative Monitoring of the Skeletal Muscle in Neuromuscular Disorders. Radiology. 2021;300(3):652–60.PubMedCrossRef
Metadata
Title
Multiparametric quantification of T1 and T2 relaxation time of bone metastasis in comparison with red or fatty bone marrow using magnetic resonance fingerprinting
Authors
Hokyun Byun
Dongyeob Han
Ho Jong Chun
Sheen-Woo Lee
Publication date
02-12-2023
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology / Issue 6/2024
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-023-04521-2

Other articles of this Issue 6/2024

Skeletal Radiology 6/2024 Go to the issue

Scientific Article

Comparison of conventional MR arthrography and 3D volumetric MR arthrography in detection of cartilage defects accompanying glenoid labrum pathologies

Scientific Article

Ankle, knee, and elbow arthrography: 2022 survey of Society of Skeletal Radiology members

Test Yourself: Answer

A painful finger—answer: Dieterich’s disease

Case Report

Fracture of an aberrant os styloideum: a unique case report

Review Article

Radiological evaluation before and after treatment with an osseointegrated bone-anchor following major limb amputation—a guide for radiologists

Scientific Article

The ‘nutcracker’ spino-laminar fracture: evaluation as a sentinel lesion of a hyperextension mechanism in cervical spine trauma